checkAd

     125  0 Kommentare GLOBAL PHARMACEUTICAL LEADER SETS SIGHT ON SUSTAINABLE FUTURE FOR THE SECTOR BY SETTING CHALLENGING SBTI NET ZERO TARGET

    Pharmanovia unveils results in new Sustainability Report and pledges commitment to new environmental and sustainability targets

    • Pilot transition from air freight to sea freight cut potential CO2 emissions by c.470,000kg
    • Employee ESG performance objective achieves 98% completion rate

    BASILDON, England, June 6, 2023 /PRNewswire/ -- Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has today announced increased targets to divert 40% of its air shipments to sea in 2023, and 75% by the end of 2028. 

    Pharmanovia has made the pledge as it revealed the significant progress made towards achieving its ambitious science-backed ESG initiatives in its new Sustainability Report. Its industry-leading air-to-sea pilot scheme, which focused on its Spain-to-Australia freight route, cut an estimated 470,000kg in potential CO2 emissions in 2022 - reducing Scope 3 upstream transport emissions by 18%. 

    This initiative demonstrates Pharmanovia's role as an industry leader on carbon reduction and follows a recent report which stated just 16 of 500 pharmaceutical companies measured their entire Scope 3 emissions.

    Additional highlights from the report include: 

    • Scope 2 emissions decreasing by 13% in 2022, due to lower direct electricity demand within the office space
    • The company's packaging audit seeing a 52% increase in the percentage of products packed with at least one fully recyclable component, up from 12% in 2021 to 64% in 2022
    • Strong progress in an initiative which saw Pharmanovia set ESG goals all employees across its global offices as part of annual performance awards. Employees achieved a 98% completion rate of the compliance training, including ESG modules

    Other initiatives include a 2030 target being established for Pharmanovia's transition to an electric hybrid vehicle fleet, while technology is also being embraced to strengthen the company's already robust Supply Chain Policy. A digital due diligence tool has been piloted and will be rolled out further in 2023 to provide continuous and automated monitoring of all partnerships, including their own ESG activities.

    Seite 1 von 2



    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    GLOBAL PHARMACEUTICAL LEADER SETS SIGHT ON SUSTAINABLE FUTURE FOR THE SECTOR BY SETTING CHALLENGING SBTI NET ZERO TARGET Pharmanovia unveils results in new Sustainability Report and pledges commitment to new environmental and sustainability targets Pilot transition from air freight to sea freight cut potential CO2 emissions by c.470,000kgEmployee ESG performance …

    Schreibe Deinen Kommentar

    Disclaimer